• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Bolsonaro emerges as risk factor for Brazil IPO pipeline

September 14, 2021 by David Barret Leave a Comment

September 14, 2021

By Carolina Mandl

SAO PAULO (Reuters) – Competition, the pandemic and sectoral demand are common challenges facing companies planning initial public offerings (IPOs), but Brazilian companies have started to flag a new risk: political upheaval from far-right President Jair Bolsonaro.

Cosmetics maker Coty and retailer Cencosud’s Brazilian units included the risk of a presidential impeachment in their recent offering prospectuses, while Coca-Cola Co’s distributor Solar Bebidas SA cautioned about turmoil ahead of the 2022 presidential elections.

Bolsonaro’s recent confrontation with Brazil’s Supreme Court amid an economic crisis has raised fears over the country’s reform process and threatens to poison the environment for 25 IPOs-in-waiting, which – added to this year’s 44 listings so far – would break Brazil’s record for IPOs.

Last week, Bolsonaro toned down his fight with the country’s top court, which authorized probes of him and his allies based on allegations that they had attacked Brazil’s democratic institution.

But market participants still question how long the truce will last. The Bovespa benchmark is down 2.9% this year in U.S. dollar terms, one of just five global indexes in negative territory for the year.

“The outlook for IPOs is more challenging. A potential institutional crisis may reduce chances of approval of reforms needed to boost the economy’s growth”, said Gustavo Miranda, investment banking head at Banco Santander Brasil SA.

Even before the pro-Bolsonaro demonstrations on Sep. 7, IPOs were facing a bumpier time amid sluggish growth, high unemployment and a severe drought pressuring food and energy prices.

Cement maker Intercement Brasil decided to cancel its share offering in July as investors offered lower valuations, while aluminum producer Companhia Brasileira de Aluminio, among others, had to slash their offer prices to sell their shares.

“We have been advising companies that are planning an IPO to be ready in case market conditions recover over the coming weeks,” said Roderick Greenlees, head of investment banking at Itau BBA, ruling out a complete shutdown of markets for share offerings.

So far this month the only two companies that are braving the market to try to conclude IPOs are gym chain BlueFit and pharma company Althaia, both slated to price next week.

MAGNIFYING GLASS

Poor performance among IPOs is also depressing investors’ appetite for new transactions, said Marcelo Millen, head of equities capital markets at Citigroup in Brazil. Nearly half of the companies listed over the last two months are trading below their IPO prices.

Asset managers, facing a paucity of new money to invest in additional shares, have grown especially picky. Stock and hedge funds had net outflows in September, although most still show inflows for the year.

“We are looking at new IPOs with a magnifying glass because we expect more volatility as the 2022 elections approach,” said Sara Delfim, managing partner at asset management firm Dahlia Capital, adding that some sectors may be able to bypass the current turbulence.

Brazilian companies considering IPOs in the United States such as fintech Nubank, payments company Conductor and Hotmart, a platform for content creators may buck the election volatility, as their growth is less reliant on the macro environment.

(Reporting by Carolina Mandl, additional reporting by Tatiana Bautzer and Paula Laier; Editing by Christian Plumb and Aurora Ellis)

Source Link Bolsonaro emerges as risk factor for Brazil IPO pipeline

David Barret
David Barret

Related posts:

  1. End of the summer: Events that may shake markets in September
  2. Taliban tells Berlin it will welcome German companies, aid
  3. China will improve opening up of capital market – securities regulator
  4. Vietnam’s capital ramps up testing after extending COVID-19 curbs

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Man Broke Down Wall In His Basement And Discovered An Ancient Underground City That Once Housed 20,000 People
  • Same-Sex Penguin Couple Adopt And Raise Chick – And They’ve All Got 10/10 Names
  • Dolphins May Not “See” With Echolocation, But Instead “Feel” With It
  • Confirmed! Comet 3I/ATLAS Is Indeed An Interstellar Visitor, Quite Different From Its Predecessors
  • At 192, Jonathan – The Oldest Living Land Animal – Has Lived Through 40 US Presidents
  • 300,000-Year-Old Wooden Tools “Made By Denisovans” Discovered In China
  • Why Do Cats Eyes Glow? For The Same Reason Great White Sharks’ Do, Silly
  • G-astronomical News: Michelin-Starred Meal To Be Served On The ISS
  • In 2032, Earth May Witness A Once-In-5,000-Year Event On The Moon
  • Brand New Microscope Designed For Underwater Reveals Stunning Details Of Corals
  • The Atlantic’s Major Circulation Current Is Showing Worrying Signs, But Is Collapse Near?
  • “The Rings Held The Answer”: How We Finally Figured Out Saturn’s Day Length In 2019
  • Mystery Of Leonardo Da Vinci’s “Vitruvian Man” Solved By A Dentist And A Protractor
  • Asteroid Ryugu’s Latest Mineral Is As Weird As Finding “A Tropical Seed In The Arctic”
  • IFLScience The Big Questions: Are We Living Through A Sixth Mass Extinction?
  • Alien Abduction Or A Trick Of The Mind? A Down To Earth Explanation Of Close Encounters
  • Six Months Into Trump’s Presidency, Americans Report Record Low Pride In Being American
  • TikToker Unknowingly Handles Extremely Venomous Cone Snail And Lives To Tell The Tale
  • Scientists Sequence Oldest Egyptian DNA To Date, From A Whopping 4,800 Years Ago
  • “Uncharted Waters”: Large Hadron Collider Begins Colliding Oxygen For The First Time
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version